Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study

• by Theresa Klinger, Katharina Müller, Ricarda Graf, Matthias Augustin, Kristina Hagenström

• June 22, 2026

PRP May Offer the Strongest Hair Transplant Evidence

Structured review highlights stronger evidence for platelet-rich plasma than for exosome-based and other emerging regenerative therapies while underscoring the need for standardized transplantation-specific research.

• by Andrea Surnit

• July 17, 2026

• 4 min

Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”

• by Saroja Rao, Isabella Midura, Kathyana P. Santiago Mangual, Leon I. Igel, Katherine H. Saunders, Jocelyn Carter, Jenny E. Murase, Arianne Shadi Kourosh

• August 11, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

• by Kathryn Wighton

• August 10, 2026

• 1 min